MARY K. PENDERGAST

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oruka Therapeutics, Inc.

Filing Date Source Excerpt
2008-04-23 Mary K. Pendergast(1)(2)* 57 Director 2002 (1) Member of Nominating and Corporate Governance Committee (2) Member of Audit Committee The following table sets forth the compensation earned by or awarded to the Company’s non-employee directors during the fiscal year ended December 31, 2007: Mary K. Pendergast $30,000 $40,115 $0 $0 $0 $0 $70,115
2009-04-30 Mary K. Pendergast Ms. Pendergast has served as a member of the Company 2 Board of Directors since May 2002. Since September 2003, Ms. Pendergast has been president of Pendergast Consulting. Ms. Pendergast served as Executive Vice President, Government Affairs for Elan Corporation from 1998 to December 2003.
2010-04-07 Ms. Pendergast, age 59, has served as a member of the Company 27s Board of Directors since the merger and as a member of Nuvelo 27s Board of Directors since May 2002. ... Ms. Pendergast also has extensive knowledge of the Company 27s business from her experience as a Board and Committee member of Nuvelo, Inc. prior to the merger, and as a member of the ARCA Board and Committees since January 2009, including as Chairman of the Nominating and Corporate Governance Committee.
2011-03-30 Ms. Mary K. Pendergast is not standing for re-election at the Annual Meeting and her term as a director will expire at the Annual Meeting. ... The Audit Committee is composed of three directors: Ms. Pendergast, Dr. Sobel and Dr. Zabriskie. ... The following table shows for the fiscal year ended December 31, 2010 certain information with respect to the compensation of all non-employee directors of the Company: ... Mary K. Pendergast 45,000 6,435 51,435.

Data sourced from SEC filings. Last updated: 2026-02-03